港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

诺诚健华

12.940

-0.080-0.61%

成交量：211.30万

成交额：2,733.00万

市值：228.00亿

市盈率：-47.93

高：13.150

开：12.980

低：12.860

收：13.020

52周最高：20.620

52周最低：5.290

股本：17.62亿

香港流通股本：14.94亿

量比：0.36

换手率：0.14%

股息：- -

股息率：- -

每股收益(LYR):-0.270

净资产收益率：-3.55%

总资产收益率：-2.10%

市净率：3.06

市盈率(LYR):-47.93

市销率: 14.28

数据加载中...

总览公司新闻资讯公告

诺诚健华[14C]ICP - 488启动Ⅰ期临床适应症为银屑病

国元国际：给予诺诚健华(09969)目标价16.81港元评级“买入”

审批进度加快，年末多款创新药集中获批

创新药迎来新一轮收获期！这些公司增长潜力巨大

89.1%ORR+96.4%DCR，中国首款新一代TRK抑制剂获批上市，暴击NTRK肿瘤

普华永道徐佳：中国创新药迎分水岭，量质转型呈分化格局

21世纪经济报道

每日卖空追踪 | 诺诚健华 12月23日卖空量成交15万股，卖空比例为3.33%

诺诚健华12月23日遭主力抛售106.0万元

诺诚健华新型TYK2抑制剂ICP-488治疗皮肤型红斑狼疮Ⅱ期临床试验获CDE批准

医药生物行业跟踪周报：银屑病口服TYK2/IL23双雄并立格局确立建议关注益方生物诺诚健华海思科等

【医药】全国医疗保障工作会议召开，部署2026年重点工作——医药生物行业周报

渤海证券研究

港股异动 | 诺诚健华(09969)涨超4% 自研新型TYK2抑制剂ICP-332治疗CSU获批准开展II/III期临床试验

医药股集体走高药明生物(02269)涨5.93% 机构料明年板块稳中向好态势延续

获批临床 | 诺诚健华新型TYK2抑制剂获批II/III期临床

奥布替尼SLE临床试验突破背后诺诚健华单产品依赖隐忧｜创新药观察

华夏时报网

自免BTK爆发，红斑狼疮重大突破

每日卖空追踪 | 诺诚健华 12月17日卖空量成交19.1万股，卖空比例为4.94%

美国投行分析师看好奥布替尼治疗多发性硬化的差异化优势

阿斯利康联合第一三共ADC药物获批；诺诚健华奥布替尼SLE研究达主要终点；复星医药拟14亿元控股绿谷医药

创新药概念再度走低诺诚健华(09969.HK)跌超5%

每日经济新闻

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/09969/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09969","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09969\",,,,,undefined,":{"symbol":"09969","market":"HK","secType":"STK","nameCN":"诺诚健华","latestPrice":12.94,"timestamp":1768550905010,"preClose":13.02,"halted":0,"volume":2112968,"delay":0,"floatShares":1494000000,"shares":1762000000,"eps":-0.27,"marketStatus":"休市中","change":-0.08,"latestTime":"01-16 16:08:25","open":12.98,"high":13.15,"low":12.86,"amount":27329987,"amplitude":0.022273,"askPrice":12.95,"askSize":22000,"bidPrice":12.94,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.143,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768786200000},"marketStatusCode":7,"adr":0,"listingDate":1584892800000,"exchange":"SEHK","adjPreClose":13.02,"openAndCloseTimeList":[[1768527000000,1768536000000],[1768539600000,1768550400000]],"volumeRatio":0.3593116104291617,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"诺诚健华","latestPrice":22.05,"timestamp":1768546800000,"preClose":22.01,"halted":0,"volume":5156100,"delay":0,"premium":"-47.56"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09969\",,,,,undefined,":{"symbol":"09969","floatShares":1494000000,"roa":"-2.10%","roe":"-3.55%","lyrEps":-0.27,"volumeRatio":0.3593116104291617,"shares":1762000000,"dividePrice":0,"high":13.15,"amplitude":0.022273,"preClose":13.02,"low":12.86,"week52Low":5.29,"pbRate":"3.06","psRate":"14.28","week52High":20.62,"institutionHeld":0,"latestPrice":12.94,"committee":-0.913043,"eps":-0.27,"divideRate":0,"volume":2112968,"delay":0,"ttmEps":-0.143,"open":12.98,"prevYearClose":12.3,"prevWeekClose":13.48,"prevMonthClose":12.3,"prevQuarterClose":12.3,"fiveDayClose":13.48,"twentyDayClose":13.28,"sixtyDayClose":14.47},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09969\",params:#limit:5,,,undefined,":[{"date":"2025-11-13","symbol":"09969","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1762997400000,"name":null,"time":"","dateTimestamp":1762963200000,"actualEps":null},{"date":"2025-08-19","symbol":"09969","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755567000000,"name":null,"time":"","dateTimestamp":1755532800000,"actualEps":null},{"market":"HK","date":"2025-05-13","symbol":"09969","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1747065600000,"reportTimeType":"post","actualEps":null},{"market":"HK","date":"2025-03-27","symbol":"09969","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1743004800000,"reportTimeType":"post","actualEps":null},{"market":"HK","date":"2024-11-11","symbol":"09969","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1731254400000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09969\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09969\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.8333,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8333,"analysts":6,"updateTime":1758556800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09969\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09969","date":"2026-01-15","current":-90.48951,"percent":0.196429,"low":-281.989741,"twenty":-97.285068,"median":-39.440352,"eighty":-15.051732,"high":-6.513911,"avg":-62.866319,"sd":62.451376,"marketCap":25198541585},"quantilePoints":[{"date":"2021-01-22","current":-6.572366,"twenty":-6.807003,"median":-6.689511,"eighty":-6.390421,"marketCap":16939631187},{"date":"2021-01-29","current":-6.706986,"twenty":-6.801722,"median":-6.686179,"eighty":-6.475137,"marketCap":17429513977},{"date":"2021-02-05","current":-10.455478,"twenty":-6.870692,"median":-6.732411,"eighty":-6.523326,"marketCap":27008011673},{"date":"2021-02-11","current":-11.304734,"twenty":-8.580835,"median":-6.790634,"eighty":-6.543563,"marketCap":29243628082},{"date":"2021-02-19","current":-12.371837,"twenty":-9.808108,"median":-6.801435,"eighty":-6.566076,"marketCap":32018023567},{"date":"2021-02-26","current":-10.953013,"twenty":-11.301264,"median":-6.832035,"eighty":-6.575713,"marketCap":28283837212},{"date":"2021-03-05","current":-10.375038,"twenty":-11.367333,"median":-6.876229,"eighty":-6.604028,"marketCap":26724177047},{"date":"2021-03-12","current":-10.731509,"twenty":-11.344944,"median":-8.456096,"eighty":-6.667557,"marketCap":27593987524},{"date":"2021-03-19","current":-11.166818,"twenty":-11.344944,"median":-9.664985,"eighty":-6.68418,"marketCap":28703745717},{"date":"2021-03-26","current":-60.784816,"twenty":-11.344944,"median":-9.961068,"eighty":-6.693006,"marketCap":28253843747},{"date":"2021-04-01","current":-59.909467,"twenty":-11.560721,"median":-10.28135,"eighty":-6.706986,"marketCap":27773948312},{"date":"2021-04-09","current":-61.00406,"twenty":-11.909617,"median":-10.455478,"eighty":-6.722241,"marketCap":28343824141},{"date":"2021-04-16","current":-66.722727,"twenty":-12.968354,"median":-10.690835,"eighty":-6.746733,"marketCap":31118219626},{"date":"2021-04-23","current":-80.348501,"twenty":-59.837475,"median":-10.76597,"eighty":-6.776893,"marketCap":37566814536},{"date":"2021-04-30","current":-78.581189,"twenty":-60.872514,"median":-10.94893,"eighty":-6.795607,"marketCap":36891961581},{"date":"2021-05-07","current":-78.710067,"twenty":-63.692575,"median":-11.138361,"eighty":-6.80043,"marketCap":37191896228},{"date":"2021-05-14","current":-68.122207,"twenty":-67.511366,"median":-11.238387,"eighty":-6.801866,"marketCap":32167990890},{"date":"2021-05-21","current":-69.69093,"twenty":-67.547224,"median":-11.329865,"eighty":-6.807003,"marketCap":32917827508},{"date":"2021-05-28","current":-70.268537,"twenty":-70.037494,"median":-11.403416,"eighty":-6.828484,"marketCap":33517696802},{"date":"2021-06-04","current":-74.551976,"twenty":-72.957121,"median":-11.757896,"eighty":-6.856675,"marketCap":35392288346},{"date":"2021-06-11","current":-82.929333,"twenty":-74.632459,"median":-12.125579,"eighty":-6.870692,"marketCap":39366422418},{"date":"2021-06-18","current":-76.759508,"twenty":-75.543088,"median":-12.841798,"eighty":-6.884964,"marketCap":36142124963},{"date":"2021-06-25","current":-84.138061,"twenty":-77.555023,"median":-36.148411,"eighty":-7.102402,"marketCap":39591373404},{"date":"2021-07-02","current":-87.477967,"twenty":-78.505326,"median":-59.849474,"eighty":-7.8324,"marketCap":41091046639},{"date":"2021-07-09","current":-89.802784,"twenty":-78.818236,"median":-60.565674,"eighty":-9.079792,"marketCap":42140817903},{"date":"2021-07-16","current":-97.155191,"twenty":-80.178997,"median":-61.09196,"eighty":-9.174239,"marketCap":45590066344},{"date":"2021-07-23","current":-89.174033,"twenty":-81.210674,"median":-61.918281,"eighty":-9.664985,"marketCap":41840883256},{"date":"2021-07-30","current":-81.548777,"twenty":-81.566046,"median":-66.538371,"eighty":-9.732614,"marketCap":38391634816},{"date":"2021-08-06","current":-77.116021,"twenty":-81.548777,"median":-66.891695,"eighty":-9.843889,"marketCap":36217108625},{"date":"2021-08-13","current":-73.82223,"twenty":-81.277531,"median":-67.529295,"eighty":-10.078248,"marketCap":34717435390},{"date":"2021-08-20","current":-62.551464,"twenty":-81.229292,"median":-68.122207,"eighty":-10.187662,"marketCap":29333608476},{"date":"2021-08-27","current":-94.857865,"twenty":-81.229292,"median":-68.321573,"eighty":-10.375038,"marketCap":30368383008},{"date":"2021-09-03","current":-104.418331,"twenty":-81.720058,"median":-69.144018,"eighty":-10.455478,"marketCap":33442713140},{"date":"2021-09-10","current":-99.246522,"twenty":-82.91461,"median":-70.152107,"eighty":-10.578836,"marketCap":31868056243},{"date":"2021-09-17","current":-96.496141,"twenty":-84.138061,"median":-70.909793,"eighty":-10.68549,"marketCap":30893268641},{"date":"2021-09-24","current":-94.812779,"twenty":-89.29803,"median":-72.265558,"eighty":-10.694041,"marketCap":30368383008},{"date":"2021-09-30","current":-98.229739,"twenty":-90.233654,"median":-73.255764,"eighty":-10.717377,"marketCap":31568121596},{"date":"2021-10-08","current":-88.760803,"twenty":-89.873798,"median":-73.831012,"eighty":-10.752186,"marketCap":28523784929},{"date":"2021-10-15","current":-93.503376,"twenty":-91.251243,"median":-73.927904,"eighty":-10.769046,"marketCap":30068448361},{"date":"2021-10-22","current":-92.605331,"twenty":-92.569994,"median":-74.551976,"eighty":-10.842135,"marketCap":29993464700},{"date":"2021-10-29","current":-86.707782,"twenty":-92.486443,"median":-75.308413,"eighty":-10.948113,"marketCap":28013896029},{"date":"2021-11-05","current":-83.877357,"twenty":-92.083624,"median":-76.2523,"eighty":-11.006965,"marketCap":27144085553},{"date":"2021-11-12","current":-89.532562,"twenty":-91.507654,"median":-77.088288,"eighty":-11.10808,"marketCap":29093660759},{"date":"2021-11-19","current":-100.982401,"twenty":-92.613608,"median":-77.67864,"eighty":-11.149744,"marketCap":32767860184},{"date":"2021-11-26","current":-95.174918,"twenty":-93.324085,"median":-78.047302,"eighty":-11.175846,"marketCap":30893268641},{"date":"2021-12-03","current":-86.237207,"twenty":-93.324085,"median":-78.581189,"eighty":-11.228587,"marketCap":28043889494},{"date":"2021-12-10","current":-87.287186,"twenty":-93.2603,"median":-78.764151,"eighty":-11.294325,"marketCap":28433804535},{"date":"2021-12-17","current":-73.895302,"twenty":-93.006888,"median":-78.710067,"eighty":-11.324839,"marketCap":24054758689},{"date":"2021-12-24","current":-69.222252,"twenty":-92.696383,"median":-78.543257,"eighty":-11.361164,"marketCap":22555085454},{"date":"2021-12-31","current":-70.266072,"twenty":-92.616367,"median":-78.047302,"eighty":-11.377017,"marketCap":22945000495},{"date":"2022-01-07","current":-62.512372,"twenty":-69.160502,"median":-68.07179,"eighty":-62.472117,"marketCap":20335569066},{"date":"2022-01-14","current":-64.308536,"twenty":-68.335953,"median":-66.26441,"eighty":-62.725874,"marketCap":20965431825},{"date":"2022-01-21","current":-59.663909,"twenty":-68.102117,"median":-63.53604,"eighty":-61.806614,"marketCap":19495752055},{"date":"2022-01-28","current":-50.982136,"twenty":-67.5487,"median":-62.462053,"eighty":-59.19373,"marketCap":16616379443},{"date":"2022-02-04","current":-53.308904,"twenty":-67.199974,"median":-62.14924,"eighty":-56.710079,"marketCap":17366216061},{"date":"2022-02-11","current":-54.579723,"twenty":-67.159035,"median":-61.774548,"eighty":-55.804225,"marketCap":17816118031},{"date":"2022-02-18","current":-57.970412,"twenty":-65.369785,"median":-60.086138,"eighty":-55.804225,"marketCap":19015856619},{"date":"2022-02-25","current":-55.821202,"twenty":-64.308536,"median":-59.102768,"eighty":-55.804225,"marketCap":18356000396},{"date":"2022-03-04","current":-53.155717,"twenty":-63.53604,"median":-58.795615,"eighty":-55.804225,"marketCap":17486189920},{"date":"2022-03-11","current":-47.483311,"twenty":-62.868209,"median":-58.192596,"eighty":-54.579723,"marketCap":15596601644},{"date":"2022-03-18","current":-52.074017,"twenty":-62.512372,"median":-58.108317,"eighty":-52.794465,"marketCap":17036287949},{"date":"2022-03-25","current":-231.99896,"twenty":-64.308536,"median":-58.186382,"eighty":-52.794465,"marketCap":18415987325},{"date":"2022-04-01","current":-227.949339,"twenty":-68.07179,"median":-58.429837,"eighty":-53.155717,"marketCap":18116052678},{"date":"2022-04-08","current":-247.844114,"twenty":-70.032053,"median":-59.128383,"eighty":-53.278267,"marketCap":19705706307},{"date":"2022-04-14","current":-230.495267,"twenty":-220.525356,"median":-59.434689,"eighty":-53.401639,"marketCap":18296013467},{"date":"2022-04-22","current":-207.546441,"twenty":-218.295578,"median":-60.252161,"eighty":-53.909967,"marketCap":16166477473},{"date":"2022-04-29","current":-215.637771,"twenty":-216.650534,"median":-61.774548,"eighty":-54.633095,"marketCap":16526399049},{"date":"2022-05-06","current":-199.685414,"twenty":-215.095307,"median":-61.886744,"eighty":-54.811408,"marketCap":15176693138},{"date":"2022-05-13","current":-204.930659,"twenty":-212.925449,"median":-62.512372,"eighty":-55.20443,"marketCap":15296666997},{"date":"2022-05-20","current":-207.642814,"twenty":-212.9122,"median":-63.922288,"eighty":-55.404567,"marketCap":15716575502},{"date":"2022-05-27","current":-197.312961,"twenty":-212.9122,"median":-67.159035,"eighty":-55.804225,"marketCap":14921748688},{"date":"2022-06-02","current":-207.108143,"twenty":-211.698411,"median":-68.07179,"eighty":-55.817807,"marketCap":15746568967},{"date":"2022-06-10","current":-240.28287,"twenty":-213.326849,"median":-69.29601,"eighty":-55.983037,"marketCap":18146046143},{"date":"2022-06-17","current":-237.365825,"twenty":-219.733756,"median":-196.955695,"eighty":-56.21125,"marketCap":17906098425},{"date":"2022-06-24","current":-272.85846,"twenty":-226.70875,"median":-197.31407,"eighty":-56.619701,"marketCap":20665497178},{"date":"2022-06-30","current":-265.394964,"twenty":-228.989558,"median":-199.772508,"eighty":-56.749264,"marketCap":20065627884},{"date":"2022-07-08","current":-267.103524,"twenty":-232.125378,"median":-200.928425,"eighty":-57.172181,"marketCap":20215595207},{"date":"2022-07-15","current":-232.801806,"twenty":-235.473783,"median":-202.752888,"eighty":-57.756931,"marketCap":17456196455},{"date":"2022-07-22","current":-235.447365,"twenty":-237.817609,"median":-204.930659,"eighty":-58.01817,"marketCap":17666150708},{"date":"2022-07-29","current":-220.787379,"twenty":-236.780157,"median":-206.12009,"eighty":-58.119978,"marketCap":16586385979},{"date":"2022-08-05","current":-234.560194,"twenty":-235.824303,"median":-207.546441,"eighty":-58.178479,"marketCap":17576170314},{"date":"2022-08-12","current":-243.434734,"twenty":-237.397423,"median":-208.043893,"eighty":-58.19011,"marketCap":18266020002},{"date":"2022-08-19","current":-236.205555,"twenty":-237.865007,"median":-209.159388,"eighty":-58.299765,"marketCap":17546176849},{"date":"2022-08-26","current":-52.366996,"twenty":-237.397423,"median":-208.043893,"eighty":-58.01817,"marketCap":17726137637},{"date":"2022-09-02","current":-52.37784,"twenty":-236.780157,"median":-207.546441,"eighty":-56.529323,"marketCap":17666150708},{"date":"2022-09-09","current":-60.701259,"twenty":-236.279217,"median":-206.12009,"eighty":-55.942578,"marketCap":20395555985},{"date":"2022-09-16","current":-58.299417,"twenty":-235.902279,"median":-205.013904,"eighty":-56.117373,"marketCap":19407535972},{"date":"2022-09-23","current":-45.553025,"twenty":-235.445,"median":-203.469699,"eighty":-55.811016,"marketCap":14873229840},{"date":"2022-09-30","current":-42.931281,"twenty":-235.38394,"median":-201.418933,"eighty":-54.633095,"marketCap":14043998757},{"date":"2022-10-07","current":-43.365245,"twenty":-235.21077,"median":-200.142645,"eighty":-53.186354,"marketCap":14185144474},{"date":"2022-10-14","current":-44.59335,"twenty":-234.802571,"median":-197.315178,"eighty":-52.369165,"marketCap":14432149477},{"date":"2022-10-21","current":-52.201339,"twenty":-234.515394,"median":-197.049548,"eighty":-52.213414,"marketCap":16778697008},{"date":"2022-10-28","current":-49.926534,"twenty":-234.227881,"median":-69.973548,"eighty":-51.660313,"marketCap":16020038784},{"date":"2022-11-04","current":-55.762203,"twenty":-233.651313,"median":-68.109698,"eighty":-51.348913,"marketCap":18066651668},{"date":"2022-11-11","current":-56.996838,"twenty":-233.065582,"median":-67.159035,"eighty":-51.660313,"marketCap":18631234533},{"date":"2022-11-18","current":-19.301896,"twenty":-232.972963,"median":-63.922288,"eighty":-51.034144,"marketCap":20924852420},{"date":"2022-11-25","current":-16.568985,"twenty":-232.762285,"median":-62.512372,"eighty":-50.868131,"marketCap":17819646665},{"date":"2022-12-02","current":-17.73927,"twenty":-232.546362,"median":-61.857367,"eighty":-50.477964,"marketCap":19407535972},{"date":"2022-12-09","current":-20.931436,"twenty":-232.251795,"median":-60.975012,"eighty":-49.573684,"marketCap":23112611021},{"date":"2022-12-16","current":-21.492872,"twenty":-231.81888,"median":-60.252161,"eighty":-48.433662,"marketCap":23677193885},{"date":"2022-12-23","current":-23.599575,"twenty":-231.026169,"median":-59.720521,"eighty":-47.465053,"marketCap":26006098202},{"date":"2022-12-30","current":-21.576278,"twenty":-230.809004,"median":-59.653572,"eighty":-46.541507,"marketCap":24065344605},{"date":"2023-01-06","current":-22.953937,"twenty":-230.591806,"median":-59.285827,"eighty":-45.118684,"marketCap":25864952486},{"date":"2023-01-13","current":-23.352824,"twenty":-230.099256,"median":-59.153998,"eighty":-43.460394,"marketCap":26817686070},{"date":"2023-01-20","current":-21.447402,"twenty":-228.989558,"median":-58.694471,"eighty":-42.880201,"marketCap":24418208895},{"date":"2023-01-27","current":-22.186704,"twenty":-228.425764,"median":-58.608721,"eighty":-42.685866,"marketCap":25265083192},{"date":"2023-02-03","current":-22.688951,"twenty":-227.949339,"median":-58.371211,"eighty":-40.394896,"marketCap":25970811773},{"date":"2023-02-10","current":-21.182382,"twenty":-226.958169,"median":-58.246007,"eighty":-23.599575,"marketCap":24100631034},{"date":"2023-02-17","current":-13.901589,"twenty":-226.646395,"median":-58.166625,"eighty":-22.953937,"marketCap":15667174493},{"date":"2023-02-24","current":-14.200439,"twenty":-226.064147,"median":-57.877575,"eighty":-22.630334,"marketCap":15808320209},{"date":"2023-03-03","current":-14.597621,"twenty":-225.263569,"median":-57.580098,"eighty":-22.186704,"marketCap":16355259860},{"date":"2023-03-10","current":-13.37357,"twenty":-14.541926,"median":-14.0212,"eighty":-13.516348,"marketCap":14873229840},{"date":"2023-03-17","current":-13.55966,"twenty":-93.343336,"median":-50.805042,"eighty":-7.832774,"marketCap":15226094130},{"date":"2023-03-24","current":-12.877593,"twenty":-93.317448,"median":-50.409488,"eighty":-7.836261,"marketCap":14626224837},{"date":"2023-03-31","current":-14.579934,"twenty":-93.206469,"median":-49.922268,"eighty":-7.84059,"marketCap":14767370553},{"date":"2023-04-06","current":-15.495731,"twenty":-93.006888,"median":-49.487604,"eighty":-7.85339,"marketCap":15684817708},{"date":"2023-04-14","current":-17.152125,"twenty":-92.722136,"median":-48.615632,"eighty":-7.871748,"marketCap":17378566302},{"date":"2023-04-21","current":-16.481483,"twenty":-92.616367,"median":-48.264711,"eighty":-7.87417,"marketCap":16690480935},{"date":"2023-04-28","current":-15.797684,"twenty":-92.587662,"median":-47.483311,"eighty":-7.87983,"marketCap":15878893068},{"date":"2023-05-05","current":-15.736773,"twenty":-92.516988,"median":-47.344707,"eighty":-7.8934,"marketCap":15843606638},{"date":"2023-05-12","current":-18.394644,"twenty":-92.440626,"median":-45.513015,"eighty":-7.905595,"marketCap":16196470929},{"date":"2023-05-19","current":-16.319789,"twenty":-91.54812,"median":-44.601744,"eighty":-7.920733,"marketCap":14167501259},{"date":"2023-05-25","current":-15.550515,"twenty":-91.495523,"median":-44.103978,"eighty":-7.937659,"marketCap":13444129464},{"date":"2023-06-02","current":-15.132457,"twenty":-91.454039,"median":-43.326643,"eighty":-7.942165,"marketCap":13038335530},{"date":"2023-06-09","current":-15.051787,"twenty":-91.055531,"median":-42.931281,"eighty":-7.94267,"marketCap":12950119457},{"date":"2023-06-16","current":-16.298716,"twenty":-90.728529,"median":-42.36322,"eighty":-7.946397,"marketCap":13955782685},{"date":"2023-06-23","current":-13.363243,"twenty":-90.63669,"median":-41.690859,"eighty":-7.955046,"marketCap":11379873365},{"date":"2023-06-30","current":-14.760574,"twenty":-90.402866,"median":-24.167821,"eighty":-7.963759,"marketCap":12456109451},{"date":"2023-07-07","current":-15.061752,"twenty":-90.093128,"median":-23.753205,"eighty":-7.966696,"marketCap":12685471239},{"date":"2023-07-14","current":-15.307807,"twenty":-89.873798,"median":-23.361246,"eighty":-7.973293,"marketCap":13073621959},{"date":"2023-07-21","current":-15.483057,"twenty":-89.797525,"median":-22.983371,"eighty":-7.977617,"marketCap":13161838031},{"date":"2023-07-28","current":-16.850152,"twenty":-89.637145,"median":-22.750308,"eighty":-7.979226,"marketCap":14308646975},{"date":"2023-08-04","current":-16.137685,"twenty":-89.317445,"median":-22.658572,"eighty":-7.981689,"marketCap":13726420896},{"date":"2023-08-11","current":-14.247592,"twenty":-88.961229,"median":-22.248585,"eighty":-7.988619,"marketCap":12050315517},{"date":"2023-08-18","current":-15.540371,"twenty":-88.799411,"median":-22.179553,"eighty":-8.005335,"marketCap":13049615032},{"date":"2023-08-25","current":-15.862499,"twenty":-88.770926,"median":-21.967677,"eighty":-8.022345,"marketCap":13326689344},{"date":"2023-09-01","current":-13.735693,"twenty":-88.594197,"median":-21.689267,"eighty":-8.032116,"marketCap":12874609530},{"date":"2023-09-08","current":-12.779129,"twenty":-88.026373,"median":-21.492872,"eighty":-8.044689,"marketCap":11836998945},{"date":"2023-09-15","current":-12.750712,"twenty":-87.575528,"median":-21.420722,"eighty":-8.060256,"marketCap":11902252760},{"date":"2023-09-22","current":-12.774314,"twenty":-87.363498,"median":-21.324862,"eighty":-8.077074,"marketCap":11872147863},{"date":"2023-09-29","current":-12.730268,"twenty":-87.257752,"median":-21.226008,"eighty":-8.097369,"marketCap":11851504479},{"date":"2023-10-06","current":-12.248111,"twenty":-87.077348,"median":-21.175104,"eighty":-8.109493,"marketCap":11397169988},{"date":"2023-10-13","current":-12.860274,"twenty":-86.830195,"median":-20.931436,"eighty":-8.119678,"marketCap":11948926482},{"date":"2023-10-20","current":-11.828362,"twenty":-86.775847,"median":-20.769577,"eighty":-8.128435,"marketCap":10973208661},{"date":"2023-10-27","current":-12.59832,"twenty":-86.613667,"median":-20.672055,"eighty":-8.139113,"marketCap":11682486413},{"date":"2023-11-03","current":-13.376915,"twenty":-86.222732,"median":-20.523302,"eighty":-8.180476,"marketCap":12437419210},{"date":"2023-11-10","current":-14.467964,"twenty":-86.112532,"median":-20.456505,"eighty":-8.203363,"marketCap":13449029401},{"date":"2023-11-17","current":-21.736832,"twenty":-85.799946,"median":-20.523302,"eighty":-8.208618,"marketCap":13716745797},{"date":"2023-11-24","current":-21.342479,"twenty":-85.344022,"median":-20.62565,"eighty":-8.211345,"marketCap":13578769625},{"date":"2023-12-01","current":-20.123483,"twenty":-85.163944,"median":-20.624586,"eighty":-8.214283,"marketCap":12856294546},{"date":"2023-12-08","current":-19.357545,"twenty":-85.089243,"median":-20.522625,"eighty":-8.231227,"marketCap":12316975510},{"date":"2023-12-15","current":-19.973121,"twenty":-84.883204,"median":-20.512861,"eighty":-8.261638,"marketCap":12782046599},{"date":"2023-12-22","current":-20.070797,"twenty":-84.540882,"median":-20.494348,"eighty":-8.299563,"marketCap":12835976462},{"date":"2023-12-29","current":-21.273106,"twenty":-84.405138,"median":-20.520982,"eighty":-8.333686,"marketCap":13677434243},{"date":"2024-01-05","current":-19.648602,"twenty":-84.226793,"median":-20.512861,"eighty":-8.412829,"marketCap":12543872490},{"date":"2024-01-12","current":-18.736479,"twenty":-84.091044,"median":-20.380698,"eighty":-8.501355,"marketCap":11967931428},{"date":"2024-01-19","current":-17.546853,"twenty":-83.950294,"median":-20.242033,"eighty":-8.58462,"marketCap":11192662703},{"date":"2024-01-26","current":-17.549906,"twenty":-83.831245,"median":-20.19939,"eighty":-8.624257,"marketCap":11151041909},{"date":"2024-02-02","current":-15.969255,"twenty":-83.787492,"median":-20.078319,"eighty":-8.750595,"marketCap":10133775060},{"date":"2024-02-09","current":-15.704661,"twenty":-83.516556,"median":-20.030255,"eighty":-8.896795,"marketCap":10014948212},{"date":"2024-02-16","current":-16.427397,"twenty":-83.259239,"median":-19.973121,"eighty":-8.940636,"marketCap":10478105662},{"date":"2024-02-23","current":-16.374198,"twenty":-82.926388,"median":-19.872105,"eighty":-8.952897,"marketCap":10389115113},{"date":"2024-03-01","current":-16.593331,"twenty":-82.900697,"median":-19.653591,"eighty":-8.99805,"marketCap":10534716651},{"date":"2024-03-08","current":-15.499601,"twenty":-82.781603,"median":-19.595803,"eighty":-9.098681,"marketCap":9844709472},{"date":"2024-03-15","current":-16.555771,"twenty":-82.473658,"median":-19.426503,"eighty":-9.272388,"marketCap":10506236859},{"date":"2024-03-22","current":-15.949532,"twenty":-82.215448,"median":-19.372453,"eighty":-9.678511,"marketCap":10112261984},{"date":"2024-03-28","current":-15.1585,"twenty":-82.049304,"median":-19.317219,"eighty":-9.732614,"marketCap":9579995392},{"date":"2024-04-05","current":-14.492567,"twenty":-81.986707,"median":-19.279921,"eighty":-9.799379,"marketCap":9900508082},{"date":"2024-04-12","current":-14.466549,"twenty":-81.8858,"median":-19.196945,"eighty":-9.984504,"marketCap":9888343143},{"date":"2024-04-19","current":-12.106574,"twenty":-81.789146,"median":-19.012076,"eighty":-10.143896,"marketCap":8268161644},{"date":"2024-04-26","current":-13.248885,"twenty":-81.732439,"median":-19.007932,"eighty":-10.300088,"marketCap":9037144022},{"date":"2024-05-03","current":-15.373277,"twenty":-81.704803,"median":-18.894095,"eighty":-10.407214,"marketCap":10478956556},{"date":"2024-05-10","current":-14.884147,"twenty":-81.635571,"median":-18.748297,"eighty":-10.504821,"marketCap":10169635177},{"date":"2024-05-17","current":-12.138332,"twenty":-81.562592,"median":-18.686895,"eighty":-10.600167,"marketCap":9986771812},{"date":"2024-05-24","current":-10.956095,"twenty":-81.494528,"median":-18.454878,"eighty":-10.687628,"marketCap":8993504857},{"date":"2024-05-31","current":-10.474881,"twenty":-81.267883,"median":-18.243372,"eighty":-10.495672,"marketCap":8607243162},{"date":"2024-06-07","current":-10.874156,"twenty":-81.225568,"median":-18.047317,"eighty":-10.581841,"marketCap":8924246607},{"date":"2024-06-14","current":-10.786125,"twenty":-81.210674,"median":-17.938861,"eighty":-10.593863,"marketCap":8843890532},{"date":"2024-06-21","current":-11.464373,"twenty":-80.961138,"median":-17.73927,"eighty":-10.681411,"marketCap":9380329681},{"date":"2024-06-28","current":-11.6378,"twenty":-80.892663,"median":-17.547659,"eighty":-10.68549,"marketCap":9518279743},{"date":"2024-07-05","current":-12.166402,"twenty":-80.750053,"median":-17.50755,"eighty":-10.694041,"marketCap":9948449832},{"date":"2024-07-12","current":-12.437085,"twenty":-80.53613,"median":-17.238604,"eighty":-10.724443,"marketCap":10184725241},{"date":"2024-07-19","current":-11.78856,"twenty":-80.377113,"median":-17.147498,"eighty":-10.746576,"marketCap":9653828614},{"date":"2024-07-26","current":-11.303678,"twenty":-80.212898,"median":-17.081942,"eighty":-10.762845,"marketCap":9291142141},{"date":"2024-08-02","current":-11.533433,"twenty":-79.971533,"median":-16.976411,"eighty":-10.772122,"marketCap":9474465919},{"date":"2024-08-09","current":-11.585323,"twenty":-79.859458,"median":-16.900708,"eighty":-10.783632,"marketCap":9580522406},{"date":"2024-08-16","current":-11.677687,"twenty":-79.673564,"median":-16.860914,"eighty":-10.802001,"marketCap":9660656236},{"date":"2024-08-23","current":-19.539341,"twenty":-79.619308,"median":-16.871676,"eighty":-10.85607,"marketCap":10041063980},{"date":"2024-08-30","current":-20.28582,"twenty":-79.520258,"median":-16.928908,"eighty":-10.873044,"marketCap":10494691352},{"date":"2024-09-06","current":-20.924869,"twenty":-79.141496,"median":-16.986832,"eighty":-10.889418,"marketCap":10830510538},{"date":"2024-09-13","current":-23.334521,"twenty":-78.865152,"median":-17.082258,"eighty":-10.930687,"marketCap":12046107892},{"date":"2024-09-20","current":-23.014575,"twenty":-78.753335,"median":-17.147498,"eighty":-10.942929,"marketCap":11952188739},{"date":"2024-09-27","current":-23.995695,"twenty":-78.700087,"median":-17.238604,"eighty":-10.949747,"marketCap":12536661473},{"date":"2024-10-04","current":-27.021916,"twenty":-78.648535,"median":-17.487492,"eighty":-10.953717,"marketCap":14053597889},{"date":"2024-10-10","current":-27.507406,"twenty":-78.566016,"median":-17.546853,"eighty":-10.955038,"marketCap":14213458451},{"date":"2024-10-18","current":-28.033176,"twenty":-78.455506,"median":-17.644588,"eighty":-10.960814,"marketCap":14409603254},{"date":"2024-10-25","current":-28.174092,"twenty":-78.172656,"median":-17.866071,"eighty":-10.979759,"marketCap":14481118333},{"date":"2024-11-01","current":-26.31039,"twenty":-77.830425,"median":-18.047317,"eighty":-10.980185,"marketCap":13532315699},{"date":"2024-11-08","current":-28.027393,"twenty":-77.774615,"median":-18.243372,"eighty":-10.989731,"marketCap":14350036693},{"date":"2024-11-15","current":-34.418649,"twenty":-77.61704,"median":-18.454878,"eighty":-11.02852,"marketCap":13903897004},{"date":"2024-11-22","current":-31.96826,"twenty":-77.319717,"median":-18.536746,"eighty":-11.050323,"marketCap":12907910959},{"date":"2024-11-29","current":-34.015698,"twenty":-77.104928,"median":-18.742388,"eighty":-11.097987,"marketCap":13725399121},{"date":"2024-12-06","current":-34.74145,"twenty":-77.000346,"median":-18.792413,"eighty":-11.140215,"marketCap":13985222726},{"date":"2024-12-13","current":-32.634359,"twenty":-76.658066,"median":-19.000856,"eighty":-11.151468,"marketCap":13111081535},{"date":"2024-12-20","current":-31.12512,"twenty":-76.183503,"median":-19.01185,"eighty":-11.170088,"marketCap":12449324545},{"date":"2024-12-27","current":-31.325698,"twenty":-75.977114,"median":-19.073202,"eighty":-11.179897,"marketCap":12519830602},{"date":"2025-01-03","current":-29.164747,"twenty":-75.705859,"median":-19.196945,"eighty":-11.185783,"marketCap":11667583008},{"date":"2025-01-10","current":-27.131595,"twenty":-75.48749,"median":-19.279921,"eighty":-11.188644,"marketCap":10813078008},{"date":"2025-01-17","current":-28.985508,"twenty":-75.283717,"median":-19.345043,"eighty":-11.221571,"marketCap":11561262437},{"date":"2025-01-24","current":-29.911742,"twenty":-74.907576,"median":-19.416757,"eighty":-11.264218,"marketCap":12005460982},{"date":"2025-01-28","current":-29.13015,"twenty":-74.72267,"median":-19.426503,"eighty":-11.278346,"marketCap":11747583398},{"date":"2025-02-07","current":-29.940677,"twenty":-74.686115,"median":-19.551804,"eighty":-11.287386,"marketCap":12011703889},{"date":"2025-02-14","current":-33.360159,"twenty":-74.551976,"median":-19.648602,"eighty":-11.303107,"marketCap":13377094539},{"date":"2025-02-21","current":-38.23932,"twenty":-74.483316,"median":-19.789236,"eighty":-11.303678,"marketCap":15388281492},{"date":"2025-02-28","current":-46.584738,"twenty":-73.976981,"median":-19.958461,"eighty":-11.304734,"marketCap":18684864067},{"date":"2025-03-07","current":-49.400792,"twenty":-73.895302,"median":-20.030255,"eighty":-11.307272,"marketCap":19893921783},{"date":"2025-03-14","current":-45.421426,"twenty":-73.878827,"median":-20.078319,"eighty":-11.308334,"marketCap":18298067891},{"date":"2025-03-21","current":-42.988954,"twenty":-73.855407,"median":-20.201232,"eighty":-11.353885,"marketCap":17311344038},{"date":"2025-03-28","current":-40.631653,"twenty":-73.855407,"median":-20.310319,"eighty":-11.353885,"marketCap":19160960799},{"date":"2025-04-03","current":-41.177552,"twenty":-73.855407,"median":-20.488321,"eighty":-11.353885,"marketCap":19380040441},{"date":"2025-04-11","current":-38.031727,"twenty":-73.855407,"median":-20.521465,"eighty":-11.353885,"marketCap":17780562360},{"date":"2025-04-17","current":-38.953953,"twenty":-73.847601,"median":-20.624586,"eighty":-11.35444,"marketCap":18255409997},{"date":"2025-04-25","current":-44.86143,"twenty":-73.863214,"median":-20.645128,"eighty":-11.356447,"marketCap":21042050452},{"date":"2025-05-02","current":-46.342356,"twenty":-73.855407,"median":-20.715846,"eighty":-11.396744,"marketCap":21782873420},{"date":"2025-05-09","current":-42.900964,"twenty":-73.863214,"median":-20.893163,"eighty":-11.468186,"marketCap":20306835662},{"date":"2025-05-16","current":-43.718907,"twenty":-73.863214,"median":-20.997552,"eighty":-11.5144,"marketCap":20863070213},{"date":"2025-05-23","current":-73.454629,"twenty":-73.944309,"median":-21.203395,"eighty":-11.608697,"marketCap":22362088629},{"date":"2025-05-30","current":-77.820773,"twenty":-74.524512,"median":-21.294272,"eighty":-11.671094,"marketCap":23795449247},{"date":"2025-06-06","current":-80.718285,"twenty":-75.333109,"median":-21.386523,"eighty":-11.782816,"marketCap":24744397396},{"date":"2025-06-13","current":-96.466826,"twenty":-76.406933,"median":-21.47738,"eighty":-11.848574,"marketCap":29583845964},{"date":"2025-06-20","current":-85.658478,"twenty":-77.093835,"median":-21.658911,"eighty":-11.904038,"marketCap":26217719889},{"date":"2025-06-27","current":-87.640789,"twenty":-77.827815,"median":-21.765132,"eighty":-11.979561,"marketCap":26899569568},{"date":"2025-07-04","current":-90.778502,"twenty":-78.626087,"median":-22.012188,"eighty":-12.11524,"marketCap":27863937043},{"date":"2025-07-11","current":-104.713329,"twenty":-79.230176,"median":-22.222123,"eighty":-12.17538,"marketCap":32108775198},{"date":"2025-07-18","current":-120.092647,"twenty":-80.023399,"median":-22.659643,"eighty":-12.382665,"marketCap":36795755114},{"date":"2025-07-25","current":-114.396576,"twenty":-80.715954,"median":-23.01369,"eighty":-12.476578,"marketCap":35177974275},{"date":"2025-08-01","current":-114.037279,"twenty":-81.248588,"median":-23.366468,"eighty":-12.633406,"marketCap":34850806125},{"date":"2025-08-08","current":-112.336229,"twenty":-81.732439,"median":-24.032929,"eighty":-12.764873,"marketCap":34416827497},{"date":"2025-08-15","current":-125.816389,"twenty":-82.365321,"median":-26.017046,"eighty":-12.870665,"marketCap":38489030931},{"date":"2025-08-22","current":-164.105588,"twenty":-83.516556,"median":-26.615946,"eighty":-12.944185,"marketCap":37299311402},{"date":"2025-08-29","current":-147.470688,"twenty":-84.226793,"median":-27.099155,"eighty":-13.061797,"marketCap":33678407143},{"date":"2025-09-05","current":-152.775918,"twenty":-85.259203,"median":-27.551989,"eighty":-13.161519,"marketCap":34855405817},{"date":"2025-09-12","current":-163.826751,"twenty":-86.3933,"median":-27.741342,"eighty":-13.270785,"marketCap":37443905938},{"date":"2025-09-19","current":-141.373961,"twenty":-86.827205,"median":-28.030285,"eighty":-13.375577,"marketCap":32289212200},{"date":"2025-09-26","current":-150.989132,"twenty":-87.363498,"median":-28.567336,"eighty":-13.47872,"marketCap":34395801181},{"date":"2025-10-03","current":-160.337807,"twenty":-87.774593,"median":-28.721038,"eighty":-13.547778,"marketCap":36612631177},{"date":"2025-10-10","current":-127.62383,"twenty":-88.49568,"median":-29.147448,"eighty":-13.636736,"marketCap":29100032282},{"date":"2025-10-17","current":-122.857286,"twenty":-88.961229,"median":-29.79734,"eighty":-13.769173,"marketCap":27991385758},{"date":"2025-10-24","current":-119.495971,"twenty":-89.805902,"median":-29.908157,"eighty":-14.066518,"marketCap":27235455666},{"date":"2025-10-31","current":-124.754625,"twenty":-89.982206,"median":-30.32673,"eighty":-14.227175,"marketCap":28476415588},{"date":"2025-11-07","current":-122.328209,"twenty":-90.850171,"median":-31.225409,"eighty":-14.299711,"marketCap":27905121424},{"date":"2025-11-14","current":-127.209777,"twenty":-91.895661,"median":-31.900416,"eighty":-14.404588,"marketCap":29100917606},{"date":"2025-11-21","current":-106.706639,"twenty":-92.670631,"median":-32.274559,"eighty":-14.431514,"marketCap":26823354466},{"date":"2025-11-28","current":-114.328784,"twenty":-93.399222,"median":-33.546635,"eighty":-14.476128,"marketCap":28843760227},{"date":"2025-12-05","current":-110.335669,"twenty":-93.666479,"median":-34.151817,"eighty":-14.574909,"marketCap":27884203833},{"date":"2025-12-12","current":-109.624603,"twenty":-95.130582,"median":-34.639338,"eighty":-14.60296,"marketCap":27755746088},{"date":"2025-12-19","current":-102.11158,"twenty":-95.886147,"median":-35.159031,"eighty":-14.689936,"marketCap":25914461919},{"date":"2025-12-24","current":-99.050359,"twenty":-96.456924,"median":-35.649375,"eighty":-14.708658,"marketCap":25215867293},{"date":"2026-01-02","current":-93.829413,"twenty":-96.460225,"median":-37.134017,"eighty":-14.829715,"marketCap":23980748744},{"date":"2026-01-09","current":-101.519,"twenty":-96.689963,"median":-38.118841,"eighty":-14.954818,"marketCap":26010643739},{"date":"2026-01-15","current":-98.030816,"twenty":-97.285068,"median":-39.440352,"eighty":-15.051732,"marketCap":25198541585}],"updateTime":1768591505348},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09969\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2594183772","title":"诺诚健华[14C]ICP - 488启动Ⅰ期临床 适应症为银屑病","url":"https://stock-news.laohu8.com/highlight/detail?id=2594183772","media":"新浪财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594183772?lang=zh_cn&edition=fundamental","pubTime":"2025-12-26 18:31","pubTimestamp":1766745060,"startTime":"0","endTime":"0","summary":"药物临床试验登记与信息公示平台数据显示，北京诺诚健华医药科技有限公司的[14C]ICP - 488在中国健康成年男性受试者中的物质平衡和生物转化研究的Ⅰ期临床试验已启动。本次试验主要目的为定量分析健康受试者单次口服[14C]ICP - 488后排泄物中的总放射性、全血和血浆中的总放射性等；获得血浆、尿液和粪便中的代谢物谱，确定代谢和消除途径。次要目的为获得血浆中ICP - 488及其代谢产物的PK特征，评估安全性。[14C]ICP - 488为化学药物，适应症为银屑病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251226183318a47b5475&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251226183318a47b5475&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1574","BK1161"],"gpt_icon":0},{"id":"2593342479","title":"国元国际：给予诺诚健华(09969)目标价16.81港元 评级“买入”","url":"https://stock-news.laohu8.com/highlight/detail?id=2593342479","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593342479?lang=zh_cn&edition=fundamental","pubTime":"2025-12-24 14:58","pubTimestamp":1766559522,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国元国际发布研报称，预计诺诚健华2025-27年收入分别为人民币20.1亿、20.6亿、25.6亿元，净利润分别为人民币1.17亿、0.17亿、1.88亿元，公司持有现金及等价物约72亿元，现金足够进行创新研究。根据DCF模型，给予目标价16.81港元，给予买入评级，较现价有28%的升幅。CDE已批准启动奥布替尼治疗SLE的III期临床试验，预计2026年第一季度首例患者入组。Zenas支付1亿美元现金首付款。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385408.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688428","09969"],"gpt_icon":0},{"id":"2593213634","title":"审批进度加快，年末多款创新药集中获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2593213634","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593213634?lang=zh_cn&edition=fundamental","pubTime":"2025-12-24 13:56","pubTimestamp":1766555761,"startTime":"0","endTime":"0","summary":"江海证券研报认为，此次“四连发”不仅是审评审批效率的体现，更标志着中国创新药研发成果迎来一轮密集的上市收获期。2024年，我国有48个创新药获批上市。此前的12月7日，国家药监局党组成员、副局长杨胜对外表示，今年以来，中国批准上市的创新药，截至当天，达到69个，已经超过了去年全年，再次创造了历史新高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224135811953b98c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224135811953b98c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1588","09969","LU2488822045.USD","BK1574","06978","BK1161"],"gpt_icon":0},{"id":"2593497294","title":"创新药迎来新一轮收获期！这些公司增长潜力巨大","url":"https://stock-news.laohu8.com/highlight/detail?id=2593497294","media":"巨丰投顾","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593497294?lang=zh_cn&edition=fundamental","pubTime":"2025-12-24 05:53","pubTimestamp":1766526780,"startTime":"0","endTime":"0","summary":"创新药受益于BD预期带动，年初至7月医药指数大涨，8月至今震荡调整，行业整体估值处于历史平均偏低水平。此次“四连发”不仅是审评审批效率的体现，更标志着中国创新药研发成果迎来一轮密集的上市收获期。一日内批准四款重磅创新药，其中佐来曲替尼片通过优先审评程序获批，彰显了药监部门对临床急需药物加速上市的支持力度。商保创新药目录2025年首次落地，有望拉动创新药产品支付增量。创新药领域，海外权益BD交易带动资产重估。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224055436a4705042&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224055436a4705042&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03759","09969","BK1574","01789","BK1161","BK1576","06978","01801","BK1141"],"gpt_icon":0},{"id":"2593424907","title":"89.1%ORR+96.4%DCR，中国首款新一代TRK抑制剂获批上市，暴击NTRK肿瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2593424907","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593424907?lang=zh_cn&edition=fundamental","pubTime":"2025-12-24 00:01","pubTimestamp":1766505660,"startTime":"0","endTime":"0","summary":"2025年12月11日，诺诚健华自主研发的新一代TRK抑制剂佐来曲替尼（ICP-723）通过NMPA优先审评审批程序附条件获批上市，适用于确诊携带NTRK融合基因且符合特定条件的成人及12岁以上青少年实体瘤患者，是中国首款自主研发的新一代TRK抑制剂。该药作为第二代TRKi，能抑制多种靶点及耐药性突变，克服第一代耐药问题，且被纳入“星光计划”。临床数据显示，其疗效突出，起效快，疗效持续时间长，最长缓解时间超36个月。佐来曲替尼针对成人及青少年NTRK基因异常肿瘤的新药上市申请已提交并被纳入优先审评，预计2026年上半年获批；针对儿童患者的注册临床试验正在进行，目标2025年底提交NDA。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224025739a46ff428&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224025739a46ff428&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09969","BK1574"],"gpt_icon":0},{"id":"2593419285","title":"普华永道徐佳：中国创新药迎分水岭，量质转型呈分化格局","url":"https://stock-news.laohu8.com/highlight/detail?id=2593419285","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593419285?lang=zh_cn&edition=fundamental","pubTime":"2025-12-23 20:54","pubTimestamp":1766494448,"startTime":"0","endTime":"0","summary":"普华永道中国医药医疗行业主管合伙人徐佳博士在接受21世纪经济报道记者专访时指出，中国创新药已进入“量质转型的分水岭阶段”，呈现“头部崛起、中小突围”的分化格局，而非行业全面复苏。当前，随着2025年国家医保药品目录正式披露，支付端对创新药的支持力度","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223205718a46f0791&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223205718a46f0791&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","LU0502904849.HKD","HK0000165453.HKD","BK1583","LU1969619763.USD","09969","BK1161","LU2097828474.EUR","LU2097828631.EUR","LU0455707207.USD","06978","LU2242644610.SGD","LU2097828805.USD","01801","LU2328871848.SGD","01530","BK1589","LU2097828557.USD","BK1574","LU2097828714.EUR"],"gpt_icon":0},{"id":"2593418537","title":"每日卖空追踪 | 诺诚健华 12月23日卖空量成交15万股，卖空比例为3.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593418537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593418537?lang=zh_cn&edition=fundamental","pubTime":"2025-12-23 16:30","pubTimestamp":1766478642,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间12月23日，跌0.08%，卖空量成交15万股，较上一交易日减少50.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223163627a6c520a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223163627a6c520a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09969"],"gpt_icon":0},{"id":"2593424149","title":"诺诚健华12月23日遭主力抛售106.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593424149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593424149?lang=zh_cn&edition=fundamental","pubTime":"2025-12-23 16:15","pubTimestamp":1766477706,"startTime":"0","endTime":"0","summary":"12月23日, 诺诚健华股价跌0.08%，报收13.13元，成交金额5924.0万元，换手率0.30%，振幅3.42%，量比0.62。诺诚健华今日主力资金净流出106.0万元，上一交易日主力净流出491.4万元。该股近5个交易日下跌0.68%，主力资金累计净流入313.3万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入1121.8万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223161519a6c50749&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223161519a6c50749&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1161","BK1574"],"gpt_icon":0},{"id":"2593457844","title":"诺诚健华新型TYK2抑制剂ICP-488治疗皮肤型红斑狼疮Ⅱ期临床试验获CDE批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2593457844","media":"人民财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593457844?lang=zh_cn&edition=fundamental","pubTime":"2025-12-23 09:36","pubTimestamp":1766453811,"startTime":"0","endTime":"0","summary":"【诺诚健华新型TYK2抑制剂ICP-488治疗皮肤型红斑狼疮Ⅱ期临床试验获CDE批准】诺诚健华今日宣布，公司自主研发的新型TYK2抑制剂ICP-488治疗皮肤型红斑狼疮（CLE）获国家药品监督管理局（NMPA）药品审评中心（CDE）批准开展Ⅱ期临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.eastmoney.com/a/202512233599157988.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4017","LU1223082519.USD","09969","BK1574","BK1161","688428","LU1223082196.USD","LU1223083913.SGD","BK0239","CDE"],"gpt_icon":0},{"id":"2593463647","title":"医药生物行业跟踪周报：银屑病口服TYK2/IL23双雄并立格局确立 建议关注益方生物 诺诚健华 海思科等","url":"https://stock-news.laohu8.com/highlight/detail?id=2593463647","media":"东吴证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593463647?lang=zh_cn&edition=fundamental","pubTime":"2025-12-23 00:00","pubTimestamp":1766419200,"startTime":"0","endTime":"0","summary":"2025 年12 月18 日，济民可信集团宣布，其申报的2.2 类及2.4 类新药JMX-2005 注射液已获国家药品监督管理局批准开展临床试验。随着武田新一代TYK2 抑制剂Zasocitinib 三期临床阳性顶线数据的出炉，叠加强生口服IL23 受体拮抗剂Icotrokinra 关键三期研究数据的持续兑现，银屑病口服治疗领域TYK2/IL23 双雄并立的格局正式确立。建议关注在TYK2 赛道具备差异化竞争优势的公司：如益方生物、诺诚健华等，以及布局口服IL23 相关领域的公司：如海思科等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223071133a6c31d0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223071133a6c31d0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","01276","09969","09926","01801","BK1161","02615","BK1574"],"gpt_icon":0},{"id":"2593177967","title":"【医药】全国医疗保障工作会议召开，部署2026年重点工作——医药生物行业周报","url":"https://stock-news.laohu8.com/highlight/detail?id=2593177967","media":"渤海证券研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593177967?lang=zh_cn&edition=fundamental","pubTime":"2025-12-22 09:17","pubTimestamp":1766366256,"startTime":"0","endTime":"0","summary":"本周策略本周全国医疗保障工作会议在北京召开，重点部署2026年8项重点工作，在支持商业健康保险发展，推动生育保险和长期护理保险发展，支持医药产业创新发展等方面着力布局。另外，近期AI医疗再现新进展，建议关注相关医疗服务、医药商业板块。订阅者应当充分了解各类投资风险，根据自身情况自主做出投资决策并自行承担投资风险。如因侵权行为给渤海证券造成任何直接或间接损失，渤海证券保留追究一切法律责任的权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222092629a6bf125a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222092629a6bf125a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02142","BK1574","BK1515","09969","03692","09939","BK1161"],"gpt_icon":0},{"id":"2592134408","title":"港股异动 | 诺诚健华(09969)涨超4% 自研新型TYK2抑制剂ICP-332治疗CSU获批准开展II/III期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2592134408","media":"智通财经","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592134408?lang=zh_cn&edition=fundamental","pubTime":"2025-12-19 11:17","pubTimestamp":1766114258,"startTime":"0","endTime":"0","summary":"消息面上，12月18日，据诺诚健华官微消息，公司宣布，自主研发的新型TYK2抑制剂soficitinib治疗慢性自发性荨麻疹获国家药品监督管理局药品审评中心批准开展II/III期临床试验。Soficitinib是诺诚健华自主研发的高效、高选择性的新型口服TYK2抑制剂，开发用于治疗多种T细胞相关的自身免疫性疾病，目前开发的适应症深度布局皮肤科这一广阔的市场，包括特应性皮炎、白癜风、结节性痒疹、荨麻疹等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383531.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK4134","III","09969","BK0239","BK1161","688428"],"gpt_icon":0},{"id":"2592044139","title":"医药股集体走高 药明生物(02269)涨5.93% 机构料明年板块稳中向好态势延续","url":"https://stock-news.laohu8.com/highlight/detail?id=2592044139","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592044139?lang=zh_cn&edition=fundamental","pubTime":"2025-12-19 10:23","pubTimestamp":1766111038,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股集体走高，药明生物 涨5.93%，药明合联涨4.56%，君实生物涨4.54%，康诺亚-B涨4.19%，荣昌生物涨3.98%，科伦博泰生物-B涨4.00%，泰格医药涨4.30%，复宏汉霖涨3.72%，诺诚健华涨3.26%。交银国际发布医药行业周报，展望2026年，该机构认为板块稳中向好态势延续，但影响市场表现的核心因素或呈分化态势，后续选股逻辑或将重回基本面和估值，即关注存在基本面预期差、当前仍被低估的个股。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971870","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","LU1242518931.SGD","LU1688375341.USD","LU0823426480.USD","HK0000165453.HKD","LU0417516738.SGD","LU0708995583.HKD","LU0823426308.USD","02268","LU0359202008.SGD","LU1880383366.USD","LU0348825331.USD","LU0572944931.SGD","LU1969619763.USD","09969","LU0588546209.SGD","BK1161","LU0417516902.SGD","LU0196878994.USD","IE00B0JY6N72.USD","LU0327786744.USD","LU0039217434.USD","03347","SG9999002562.SGD","LU0856984785.SGD","BK1610","LU0052750758.USD","09995","02696","159938","LU0051755006.USD","BK1141","LU0326950275.SGD","LU0516422366.SGD","02162","02269","01877","LU2328871848.SGD","LU0348735423.USD","LU1242518857.USD","09939","BK1521","LU0181495838.USD","06990","LU0819121731.USD","BK1574","BK1587","BK1576","SG9999014674.SGD","LU0359201612.USD"],"gpt_icon":0},{"id":"2592906727","title":"获批临床 | 诺诚健华新型TYK2抑制剂获批II/III期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2592906727","media":"医药地理","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592906727?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 17:11","pubTimestamp":1766049104,"startTime":"0","endTime":"0","summary":"12月18日，诺诚健华宣布，其自主研发的新型TYK2抑制剂soficitinib治疗慢性自发性荨麻疹获国家药品监督管理局药品审评中心批准开展II/III期临床试验。Soficitinib是一款高效、高选择性的新型口服TYK2抑制剂，被开发用于治疗多种T细胞相关的自身免疫性疾病，目前开发的适应症包括特应性皮炎、白癜风、结节性痒疹、荨麻疹等。Soficitinib通过阻断IL-4、IL-13、IL-31等驱动肥大细胞活化和炎症反应的细胞因子信号通路，从而减轻瘙痒和风团形成，改善CSU症状。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218175311a6b20bec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218175311a6b20bec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09969","BK1574"],"gpt_icon":0},{"id":"2592201369","title":"奥布替尼SLE临床试验突破背后 诺诚健华单产品依赖隐忧｜创新药观察","url":"https://stock-news.laohu8.com/highlight/detail?id=2592201369","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592201369?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 15:03","pubTimestamp":1766041380,"startTime":"0","endTime":"0","summary":"12月15日，生物医药公司诺诚健华宣布，其核心产品奥布替尼用于治疗系统性红斑狼疮（SLE）的IIb期临床研究达到主要终点，并已获国家药品监督管理局批准开展Ⅲ期临床试验。这一进展虽标志着该药在开拓自身免疫疾病这一巨大新市场的道路上迈出关键一步，但其通往成功商业化的道路仍布满不确定性，或将面临来自临床试验、市场竞争及公司战略的多重严峻挑战。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512183595356395.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512183595356395.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688428","159992","06978","09969","BK1574","BK0239","BK4077","SLE","BK1161"],"gpt_icon":0},{"id":"2592906050","title":"自免BTK爆发，红斑狼疮重大突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2592906050","media":"医曜","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592906050?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 11:19","pubTimestamp":1766027952,"startTime":"0","endTime":"0","summary":"两款BTK抑制剂在自免领域的连续获批，让该类药物一跃成为市场关注的焦点。如今BTK抑制剂在自免领域的优异临床表现，已然透露出明确的爆发潜力。在众多自免疾病中，被称为“不死癌症”的系统性红斑狼疮无疑是预期差最大的赛道。这三款药物均存在适应症局限，仅适用于部分重症SLE患者。基于这些核心优势，口服BTK抑制剂已成为全球SLE领域的研发热点，有望打破当前SLE的治疗困局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218115357a4599ea9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218115357a4599ea9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09969"],"gpt_icon":0},{"id":"2592986219","title":"每日卖空追踪 | 诺诚健华 12月17日卖空量成交19.1万股，卖空比例为4.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592986219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592986219?lang=zh_cn&edition=fundamental","pubTime":"2025-12-17 16:30","pubTimestamp":1765960242,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间12月17日，涨0.15%，卖空量成交19.1万股，较上一交易日减少85.75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163658a45615d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163658a45615d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1161","BK1574"],"gpt_icon":0},{"id":"2592998675","title":"美国投行分析师看好奥布替尼治疗多发性硬化的差异化优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2592998675","media":"同壁财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592998675?lang=zh_cn&edition=fundamental","pubTime":"2025-12-17 11:48","pubTimestamp":1765943331,"startTime":"0","endTime":"0","summary":"美国投行H.C. Wainwright分析师Matthew Caufield 给予诺诚健华合作伙伴zenas biopharma “买入”评级，理由是Zenas正在研发BTK抑制剂奥布替尼在治疗进展型多发性硬化症  方面展现出良好的前景。Caufield认为 ，凭借独特的药代动力学特征和关键性试验设计，奥布替尼依然具有差异化优势。此外，每天一次75毫克奥布替尼剂量组的疗效优于每天一次50毫克剂量组，这表明疗效呈剂量依赖性的改善趋势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217115411a45516ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217115411a45516ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1161","BK1574"],"gpt_icon":0},{"id":"2592774967","title":"阿斯利康联合第一三共ADC药物获批；诺诚健华奥布替尼SLE研究达主要终点；复星医药拟14亿元控股绿谷医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2592774967","media":"药财社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592774967?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 19:00","pubTimestamp":1765882859,"startTime":"0","endTime":"0","summary":"奥布替尼是全球首个在SLE II期临床试验中展示显著疗效的BTK抑制剂。Enhertu是阿斯利康和第一三共联合开发的ADC疗法。3复星医药拟14亿元控股绿谷医药12月15日晚间，复星医药抛出一则重磅公告，拟出资约14.12亿元控股收购绿谷医药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216203206a452814d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216203206a452814d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1515","BK1593","BK1191","BK1161","BK1574","02196","09969"],"gpt_icon":0},{"id":"2591565672","title":"创新药概念再度走低 诺诚健华(09969.HK)跌超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591565672","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591565672?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 11:21","pubTimestamp":1765855266,"startTime":"0","endTime":"0","summary":"每经AI快讯，创新药概念股再度走低，截至发稿，诺诚健华(09969.HK)跌5.09%，报12.86港元；石药集团(01093.HK)跌3.99%，报7.21港元；信达生物(01801.HK)跌3.36%，报79港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512163592831521.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512163592831521.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09969","BK1161","688428","BK0239","159992","BK1574","06978"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}